Hinge Bio
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of HB2198 in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) (NCT07491900) | Hinge Bio | 2026-03-23 |
| Single Ascending Dose Study of HB2198 in Healthy Participants (NCT07439263) | Hinge Bio | 2026-03-19 |
Track Hinge Bio automatically
Every clearance here is in the API, with alerts when new ones post.